P12821 (ACE_HUMAN) Homo sapiens (Human)

Angiotensin-converting enzyme UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

1306 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

65 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 4-10
5am8
 Heteromer
P05067; 		30-640
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×SO4; 4×PEG;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 35-42
5amb
 Heteromer
P05067; 		30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 1×PG4; 1×P6G;
Assess
Human angiotensin-converting enzyme in complex with angiotensin-II
4aph
 Heteromer
P01019; 		645-1230
1×NAG; 2×CL; 1×ZN; 1×PE4; 1×NAG; 5×ACT;
Assess
Human angiotensin-converting enzyme in complex with BPPb
4apj
 Heteromer
P01021; 		645-1229
1×NAG; 3×CL; 1×SO4; 3×PE4; 1×ACT;
Assess
Structure of full-length, monomeric, soluble somatic angiotensin I-converting enzyme showing the N-…
7q3y
monomer30-1230
1×NAG; 2×NAG; 4×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 4×NAG;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 10-16
5am9
monomer30-645
1×NAG; 1×NAG; 1×NAG; 1×GLU; 1×VAL; 1×ZN; 1×CL; 1×CA; 4×PEG;
Assess
Local refinement structure of the N-domain of full-length, monomeric, soluble somatic angiotensin I…
7q49
monomer30-645
1×NAG; 1×NAG; 4×NAG; 1×ZN; 2×NAG;
Assess
Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP
8qfx
monomer30-642
2×NAG; 1×ZN; 1×CL; 1×MG; 2×PGE; 1×12P; 1×XPE; 4×PEG; 5×EDO; 4×NAG; 1×BMA;
Assess
Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito…
7q25
monomer30-641
1×NAG; 1×NAG; 1×8J9; 1×NAG; 2×ACT; 1×1PE; 3×EDO; 2×PEG; 1×P33; 1×ZN; 1×CL; 1×MG;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 1-16
5ama
monomer30-641
1×NAG; 1×NAG; 1×ASP; 1×SER; 1×ZN; 1×CL; 1×NAG; 3×PEG; 2×P6G;
Assess
Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with BPPb
6qs1
monomer30-641
1×NAG; 1×NAG; 1×NAG; 1×XPE; 4×EDO; 2×PEG; 4×BO3; 1×PGE; 1×ZN; 2×CL; 1×MG;
Assess
Human angiotenisn converting enzyme N-domain in complex with K-26
4bzs
monomer30-641
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×PE4; 1×P6G; 1×PEG; 1×K26; 1×9X6;
Assess
Structure of human somatic angiontensin-I converting enzyme N domain with lisinopril
2c6n
monomer30-641
1×NAG; 2×NAG; 1×ZN; 1×CL; 1×LPR; 2×GOL;
Assess
Structure of human somatic angiontensin-I converting enzyme N domain
2c6f
monomer30-641
2×NAG; 3×NAG; 1×ZN; 1×CL; 2×ACT; 1×GOL;
Assess
Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito…
7q26
monomer30-640
1×NAG; 1×NAG; 1×NAG; 1×8JV; 1×ZN; 1×CL; 1×MG; 2×ACT; 1×1PE; 1×PEG; 2×EDO;
Assess
Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Omapatrilat.
6h5x
monomer30-640
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×FT8; 1×CL; 1×XPE; 1×PG4; 7×EDO;
Assess
Crystal structure of the open conformation of Angiotensin-1 converting enzyme N-domain.
6zpq
monomer30-640
1×NAG; 1×NAG; 3×BO3; 2×BCN; 1×PEG; 5×EDO; 2×PGE; 1×ZN; 1×CL; 1×MG; 1×CA;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta fluo…
5amc
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×GLY; 1×NIY; 1×ZN; 1×CL; 3×PEG;
Assess
Crystal structure A of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhi…
6en5
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×BJ2; 1×CL; 1×MG; 3×PEG; 7×EDO; 2×ACT; 1×PE3;
Assess
Crystal structure B of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhi…
6en6
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×BJ2; 1×CL; 1×MG; 2×PEG; 2×EDO; 2×ACT; 1×PGE; 1×BCN;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Ac-SD
4ufa
monomer30-639
1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; 2×PEG; 1×P6G; 1×SAC; 1×ASP;
Assess
Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with …
6tt1
monomer30-639
1×NAG; 1×NAG; 1×NAG; 2×BO3; 1×ZN; 1×1IU; 1×CL; 4×EDO; 1×PEG; 1×PGE;
Assess
Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat-Asp.
6f9r
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×D0W; 1×CL; 1×PEG; 1×PG4; 1×MG; 1×EDO; 2×ACT;
Assess
Human Angiotensin converting enzyme N-domain in complex with a phosphinic tripeptide FI
4ca6
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 1×PG4; 1×3EF;
Assess
Angiotensin Converting Enzyme N domain glycsoylation mutant (Ndom389) in complex with RXP407
3nxq
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×RX4; 1×P6G; 1×CL; 1×PEG;
Assess
human Angiotenisn converting enzyme N-domain in complex with Phosphinic tripeptide
2xyd
monomer30-639
1×NAG; 1×NAG; 1×NAG; 1×3ES; 1×ZN; 1×CL; 3×PEG; 1×PG4;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with a domain-specific…
4bxk
monomer30-639
1×NAG; 1×NAG; 1×NAG; 3×PEG; 1×P6G; 1×1IU; 1×ZN; 1×CL;
Assess
Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat.
6f9v
monomer30-638
1×NAG; 1×NAG; 1×ZN; 1×D0Z; 2×CL; 1×NAG; 2×MG; 3×EDO; 1×PEG; 1×PG4;
Assess
Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with fosinoprilat
7z6z
monomer30-638
1×NAG; 1×NAG; 1×NAG; 1×KS8; 5×PEG; 3×PGE; 2×PG4; 4×ACT; 4×EDO; 1×ZN; 1×CL; 1×CA; 1×NA;
Assess
Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito…
7q24
monomer30-638
1×NAG; 1×NAG; 1×NAG; 3×PEG; 1×P33; 1×ACT; 2×EDO; 1×P6G; 1×ZN; 1×CL; 1×MG; 1×8KC;
Assess
Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with …
6tt3
monomer30-637
1×NAG; 1×NAG; 1×NAG; 3×BO3; 1×ZN; 1×CL; 1×BJ2; 1×PGE; 1×PEG; 1×PG4; 4×EDO; 2×BCN; 1×CA;
Assess
Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with …
6tt4
monomer30-637
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×FT8; 1×CL; 1×XPE; 1×PGE; 2×EDO; 1×PEG; 1×BCN; 2×BO3;
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Lys-Pro
4ufb
monomer30-637
1×NAG; 1×NAG; 1×NAG; 1×LYS; 1×PRO; 1×ZN; 1×CL; 3×PEG; 2×P6G;
Assess
Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP
8qhl
monomer30-637
1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 2×EDO; 1×PG4; 1×PGE;
Assess
Local refinement structure of the two interacting N-domains of full-length, dimeric, soluble somati…
7q4d
monomer30-637
1×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG;
Assess
Local refinement structure of a single N-domain of full-length, dimeric, soluble somatic angiotensi…
7q4e
monomer30-637
1×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG;
Assess
Crystal structure of the open conformation of S2_S'-mutant human Angiotensin-1 converting enzyme N-…
6zpt
monomer35-638
1×NAG; 1×NAG; 1×BCN; 2×PG0; 1×ZN; 1×CL; 1×CA;
Assess
Crystal structure of Angiotensin-1 converting enzyme C-domain with inserted symmetry molecule C-ter…
6zpu
monomer646-1238
1×NAG; 1×NAG; 1×ACT; 3×EDO; 1×ZN; 2×CL;
Assess
Crystal structure of human Angiotensin-1 converting enzyme C-domain in complex with Omapatrilat.
6h5w
monomer645-1230
1×NAG; 1×NAG; 1×ZN; 2×CL; 3×FT8; 1×IMD; 3×BO3; 1×P6G; 6×EDO;
Assess
Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito…
7q27
monomer645-1230
1×NAG; 1×NAG; 3×EDO; 1×ACT; 1×ZN; 1×8KC; 2×CL; 5×BO3; 1×1PE; 1×IMD;
Assess
Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat.
6f9t
monomer645-1230
1×NAG; 1×NAG; 1×ZN; 1×D0Z; 2×CL; 2×IMD; 1×BO3; 3×EDO; 3×PEG; 1×PGE;
Assess
Crystal structure of human testis angiotensin-I converting enzyme mutant D465T
4c2o
monomer645-1230
1×NAG; 1×SO4; 2×CL; 1×ZN; 1×MLA; 1×PE4; 1×NAG; 2×ACT;
Assess
Human Angiotensin converting enzyme in complex with a phosphinic tripeptide FI
4ca5
monomer645-1230
1×NAG; 1×ZN; 2×CL; 3×ACT; 1×PEG; 1×3EF; 1×NAG;
Assess
Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat-Asp.
6f9u
monomer645-1230
1×NAG; 1×NAG; 1×ZN; 2×CL; 1×1PE; 1×D0W; 1×BO3; 2×IMD; 6×EDO; 1×PEG;
Assess
Crystal structure of human testis angiotensin-I converting enzyme mutant R522K in complex with capt…
4c2p
monomer645-1230
1×NAG; 1×ZN; 2×CL; 1×X8Z; 1×ACT; 1×GOL;
Assess
Tesis ACE co-crystal structure with ketone ACE inhibitor kAF
3bkk
monomer643-1228
1×NAG; 2×NAG; 1×ZN; 2×CL; 1×KAF;
Assess
Crystal structure of human testis angiotensin-I converting enzyme mutant R522K
4c2q
monomer645-1230
1×NAG; 1×ZN; 1×CL; 1×SO4; 1×ACT; 1×PE4;
Assess
Human testis angiotensin converting enzyme in complex with K-26
4bzr
monomer645-1229
1×NAG; 1×ACT; 1×PE4; 1×K26; 2×CL; 1×ZN; 1×NAG;
Assess
Testis ACE co-crystal structure with ketone ACE inhibitor kAW
3bkl
monomer645-1229
1×NAG; 2×NAG; 1×ZN; 2×CL; 3×ACT; 1×KAW; 1×GOL;
Assess
Crystal structure of human testis angiotensin-I converting enzyme mutant R522Q
4c2r
monomer645-1229
1×NAG; 1×ZN; 1×CL; 1×SO4; 1×ACT; 1×PE4;
Assess
Crystal structure of human testis angiotensin-I converting enzyme mutant E403R
4c2n
monomer645-1229
1×NAG; 1×ZN; 2×CL; 1×SO4; 1×PE4;
Assess
Local refinement structure of the C-domain of full-length, monomeric, soluble somatic angiotensin I…
7q4c
monomer646-1230
1×NAG; 2×NAG; 1×CL; 2×NAG;
Assess
Human Angiotensin converting enzyme in complex with phosphinic tripeptide
2xy9
monomer645-1228
1×NAG; 1×ACT; 2×CL; 1×ZN; 1×NAG; 1×EPE; 2×3ES;
Assess
Human tACE g13 mutant
2iul
monomer645-1228
1×NAG; 1×NAG; 2×ACT; 2×CL; 1×ZN;
Assess
Structure of testis ACE with RXPA380
2oc2
monomer645-1228
1×ZN; 2×CL; 1×RX3;
Assess
Complex of the anti-hypertensive drug enalaprilat and the human testicular angiotensin I-converting…
1uze
monomer645-1223
1×GLY; 1×ZN; 2×CL; 1×EAL;
Assess
Complex of the anti-hypertensive drug captopril an the human testicular angiotensin I-converting en…
1uzf
monomer645-1223
2×NAG; 1×ZN; 1×MCO; 2×CL;
Assess
Crystal Structure of Human Angiotensin Converting Enzyme (Native).
1o8a
monomer645-1223
6×NAG; 1×ACT; 1×ZN; 1×NXA; 2×CL;
Assess
Crystal Structure of Human Angiotensin Converting Enzyme in complex with lisinopril.
1o86
monomer645-1223
1×GLY; 1×ZN; 1×LPR; 2×CL;
Assess
Structural characterization of angiotensin-I converting enzyme in complex with a selenium analogue …
2ydm
monomer645-1223
1×NAG; 1×ZN; 2×CL; 1×NAG; 1×SLC;
Assess
Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito…
7q29
monomer645-1222
1×NAG; 1×NAG; 5×BO3; 1×IMD; 1×8JV; 1×PEG; 1×1PE; 2×EDO; 1×ZN; 2×CL;
Assess
Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito…
7q28
monomer645-1222
1×NAG; 1×NAG; 3×BO3; 1×8J9; 1×PEG; 2×EDO; 1×ZN; 2×CL;
Assess
Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with fosinoprilat
7z70
monomer645-1222
1×NAG; 1×KS8; 1×NAG; 2×BO3; 1×ACT; 1×IMD; 3×EDO; 1×ZN; 2×CL;
Assess
Testis ACE co-crystal structure with novel inhibitor lisW
3l3n
monomer645-1222
1×NAG; 1×ZN; 2×CL; 1×LSW;
Assess
Human tACE mutant g1234
2iux
monomer645-1222
2×NAG; 1×ACT; 1×ZN; 2×CL; 1×NXA;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7q3y.1.Amonomer0.8631-1230
1×NAG; 1×ZN;99.92
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27q3y.1.Amonomer0.8732-1143
1×ZN;99.28
Assess
Isoform 37q27.1.Amonomer0.9371-656
1×ZN; 1×8KC; 5×BO3; 1×IMD;99.16
Assess
Isoform 37q3y.1.Amonomer0.8211-656
1×NAG;93.65
Assess
Isoform 47q27.1.Amonomer0.9171-615
5×BO3; 1×IMD;99.10
Assess
Isoform 47q3y.1.Amonomer0.8011-615
2×NAG;93.22
Assess